| 
  • If you are citizen of an European Union member nation, you may not use this service unless you are at least 16 years old.

  • You already know Dokkio is an AI-powered assistant to organize & manage your digital files & messages. Very soon, Dokkio will support Outlook as well as One Drive. Check it out today!

View
 

NotesOnFaustman

This version was saved 16 years, 7 months ago View current version     Page history
Saved by PBworks
on August 16, 2007 at 2:57:37 pm
 

These are Notes on Diabetes that I have posted elsewhere

 


 

Faustman: all talk, no human results

 

I don't have time to write a full post, but when I saw Lisa's quote (below) I suddenly realized why so many people like Faustman's work!

 

Lisa wrote:

"For me, there is one cure in the works. That is at Dr. Faustman's lab. Since there is nothing really compareable to what she is doing, she will be the first."

 

The "advantage" of Faustmans work (and I mean that most sarcastically) is that SHE HAS NEVER DONE ANYTHING WITH PEOPLE. She has never cured anybody, she has never even tried to cure anybody! She has not even raised a single person's C-peptide generation or lowered insulin usage. Therefore, she can say anything, and some people will believe her. She can say her research is a cure! Is cheap! Has no side effects, works by magic! Solves the real problem. Whatever. Because she's never treated one person, there is no pesky data to show any problems in her work.

 

The "problem" (again, sarcasticly) with Dynamid Develogen and all the rest, is that they have done trails on people, so we know the weaknesses of their research. (Because Faustman hasn't done human trials, we don't know the weaknesses of her research.) Maybe this is the real reason why the first thing she did after getting her 10.6 millon from Lee, is to delay human trials by two years! As long as she doesn't test anything, her research will continue to be perfect!

 

On a slightly more serious note, Lisa, Faustman's big human trials will be testing BCG. BCG has been previously tested as a type-1 cure and as a type-1 prevention. It did neither. Faustman's only unique component is going to be different dosing. Same drug different dose. Seems like a long shot. Hopefully in 2011 when we finally hear about it, it will be redundant.

Comments (0)

You don't have permission to comment on this page.